← 返回

免疫治疗和细胞治疗中的昼夜节律:对肿瘤微环境的影响

英文原题:Circadian rhythm in immunotherapy and cellular therapy: impacts on the tumor microenvironment.

查看英文原题

Circadian rhythm in immunotherapy and cellular therapy: impacts on the tumor microenvironment.

PubMed 2025/11/20(内容时间) Acta Biochim Biophys Sin (Shanghai) Q1 · IF 4.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

免疫治疗,包括细胞治疗,已成为癌症治疗的重要支柱,与手术、化疗和放疗等既定治疗方式相辅相成。免疫治疗仅对有限比例的患者有效的临床观察,推动了对肿瘤微环境(TME)内复杂调控网络的机制研究。昼夜节律调控显著影响免疫细胞行为,包括免疫细胞的活性和细胞因子的产生,新出现的证据表明昼夜节律调控在TME中发挥关键作用,进而影响免疫治疗的有效性。临床前和临床研究结果表明,适当地安排过继性细胞治疗和免疫检查点阻断治疗的时间可提高其疗效。因此,理解昼夜节律的分子机制及其在免疫治疗中的作用,对于优化TME中细胞功能、增殖和持久性至关重要。在此,我们综述昼夜节律如何在肿瘤进展的不同阶段影响免疫治疗和TME。未来的临床方案可能整合昼夜节律和免疫治疗的概念以增强治疗反应。

展开英文摘要原文

Immunotherapy, including cellular therapy, has emerged as a crucial pillar in cancer treatment, complementing established modalities such as surgery, chemotherapy and radiotherapy. The clinical observation that immunotherapy is effective in only a limited proportion of patients inspires mechanistic research on the complicated regulatory network within the tumor microenvironment (TME).

Circadian regulation significantly affects immune cell behavior, including the activity of immune cells and cytokine production, and emerging evidence suggests the key role of circadian regulation in the TME, which subsequently affects the effectiveness of immunotherapy. Results from preclinical and clinical studies indicate that appropriate timing of adoptive cellular therapy and immune checkpoint blockade therapy improves their efficacy.

Therefore, understanding the molecular mechanism of the circadian rhythm together with its role in immunotherapy is essential for optimizing cellular function, proliferation and persistence in the TME.

Here, we review how circadian rhythms influence immunotherapy and the TME across different stages of tumor progression. Future clinical protocols may integrate concepts of circadian rhythm and immunotherapy to enhance treatment response.

论文信息

作者
Sun X、Qin L、Liang X、Wang D
单位
Bone Marrow Transplantation Center of the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou 311121, China.China
文献类型
综述
期刊
Acta biochimica et biophysica Sinica2026 Jan 25
原文标识
PubMed 41261920 · DOI 10.3724/abbs.2025203